European research initiative on chronic lymphocytic leukaemia (ERIC) guidelines for detection of minimal residual disease (MRD) in CLL using multi-parameter (4-10 CLR) flow cytometry
RAWSTRON, A., N. VILLAMOR, R. LETESTU, R. DE TUTE, C. FAZI et. al.
European research initiative on chronic lymphocytic leukaemia (ERIC) guidelines for detection of minimal residual disease (MRD) in CLL using multi-parameter (4-10 CLR) flow cytometry
Autoři
RAWSTRON, A., N. VILLAMOR, R. LETESTU, R. DE TUTE, C. FAZI, J. NOMDEDEU, C. PALACIO, Olga STEHLÍKOVÁ, S. LIPTROT, D. O BRIEN, Martin ŠPAČEK, J. DOBBER, A. KATER, P. GAMBELL, D. WESTERMAN, A. SOOSAPILLA, S. MULLIGAN, KA. KREUZER, G. LOZANSKI, G. BRACHTL, T. SHANAFELT, C. HANSON, J. JORGENSEN, B. WIERDA, L. RASSENTI, B. BROOME, T. KIPPS, C. YUAN, M. STETLER-STEVENSON, F. CRAIG, J. DELGADO, CM. ATANASIO, F. BOSCH, Michael DOUBEK, Šárka POSPÍŠILOVÁ, F. CYMBALISTA, M. HALLEK, P. HILLMEN, E. MONTSERRAT a P. GHIA
RAWSTRON, A., N. VILLAMOR, R. LETESTU, R. DE TUTE, C. FAZI, J. NOMDEDEU, C. PALACIO, Olga STEHLÍKOVÁ, S. LIPTROT, D. O BRIEN, Martin ŠPAČEK, J. DOBBER, A. KATER, P. GAMBELL, D. WESTERMAN, A. SOOSAPILLA, S. MULLIGAN, KA. KREUZER, G. LOZANSKI, G. BRACHTL, T. SHANAFELT, C. HANSON, J. JORGENSEN, B. WIERDA, L. RASSENTI, B. BROOME, T. KIPPS, C. YUAN, M. STETLER-STEVENSON, F. CRAIG, J. DELGADO, CM. ATANASIO, F. BOSCH, Michael DOUBEK, Šárka POSPÍŠILOVÁ, F. CYMBALISTA, M. HALLEK, P. HILLMEN, E. MONTSERRAT a P. GHIA. European research initiative on chronic lymphocytic leukaemia (ERIC) guidelines for detection of minimal residual disease (MRD) in CLL using multi-parameter (4-10 CLR) flow cytometry. In XV iwCLL, Cologne, Německo. 2013.
@proceedings{1130900, author = {Rawstron, A. and Villamor, N. and Letestu, R. and de Tute, R. and Fazi, C. and Nomdedeu, J. and Palacio, C. and Stehlíková, Olga and Liptrot, S. and O Brien, D. and Špaček, Martin and Dobber, J. and Kater, A. and Gambell, P. and Westerman, D. and Soosapilla, A. and Mulligan, S. and Kreuzer, KA. and Lozanski, G. and Brachtl, G. and Shanafelt, T. and Hanson, C. and Jorgensen, J. and Wierda, B. and Rassenti, L. and Broome, B. and Kipps, T. and Yuan, C. and StetlerandStevenson, M. and Craig, F. and Delgado, J. and Atanasio, CM. and Bosch, F. and Doubek, Michael and Pospíšilová, Šárka and Cymbalista, F. and Hallek, M. and Hillmen, P. and Montserrat, E. and Ghia, P.}, booktitle = {XV iwCLL, Cologne, Německo}, language = {eng}, title = {European research initiative on chronic lymphocytic leukaemia (ERIC) guidelines for detection of minimal residual disease (MRD) in CLL using multi-parameter (4-10 CLR) flow cytometry}, year = {2013} }
TY - CONF ID - 1130900 AU - Rawstron, A. - Villamor, N. - Letestu, R. - de Tute, R. - Fazi, C. - Nomdedeu, J. - Palacio, C. - Stehlíková, Olga - Liptrot, S. - O Brien, D. - Špaček, Martin - Dobber, J. - Kater, A. - Gambell, P. - Westerman, D. - Soosapilla, A. - Mulligan, S. - Kreuzer, KA. - Lozanski, G. - Brachtl, G. - Shanafelt, T. - Hanson, C. - Jorgensen, J. - Wierda, B. - Rassenti, L. - Broome, B. - Kipps, T. - Yuan, C. - Stetler-Stevenson, M. - Craig, F. - Delgado, J. - Atanasio, CM. - Bosch, F. - Doubek, Michael - Pospíšilová, Šárka - Cymbalista, F. - Hallek, M. - Hillmen, P. - Montserrat, E. - Ghia, P. PY - 2013 TI - European research initiative on chronic lymphocytic leukaemia (ERIC) guidelines for detection of minimal residual disease (MRD) in CLL using multi-parameter (4-10 CLR) flow cytometry ER -
RAWSTRON, A., N. VILLAMOR, R. LETESTU, R. DE TUTE, C. FAZI, J. NOMDEDEU, C. PALACIO, Olga STEHLÍKOVÁ, S. LIPTROT, D. O BRIEN, Martin ŠPAČEK, J. DOBBER, A. KATER, P. GAMBELL, D. WESTERMAN, A. SOOSAPILLA, S. MULLIGAN, KA. KREUZER, G. LOZANSKI, G. BRACHTL, T. SHANAFELT, C. HANSON, J. JORGENSEN, B. WIERDA, L. RASSENTI, B. BROOME, T. KIPPS, C. YUAN, M. STETLER-STEVENSON, F. CRAIG, J. DELGADO, CM. ATANASIO, F. BOSCH, Michael DOUBEK, Šárka POSPÍŠILOVÁ, F. CYMBALISTA, M. HALLEK, P. HILLMEN, E. MONTSERRAT a P. GHIA. European research initiative on chronic lymphocytic leukaemia (ERIC) guidelines for detection of minimal residual disease (MRD) in CLL using multi-parameter (4-10 CLR) flow cytometry. In \textit{XV iwCLL, Cologne, Německo}. 2013.